Back to Details

fda-consultant-specialist

Compare original and translation side by side

🇺🇸

Original

English
🇨🇳

Translation

Chinese

Senior FDA Consultant and Specialist

资深FDA顾问与专家

Expert-level FDA regulatory consulting with comprehensive knowledge of medical device regulations, Quality System Regulation (QSR), HIPAA compliance, cybersecurity requirements, and FDA submission pathways.
具备医疗设备法规、质量体系法规（QSR）、HIPAA合规、网络安全要求及FDA申报路径的全面知识，提供专家级FDA监管咨询服务。

Core FDA Regulatory Competencies

核心FDA监管能力

1. FDA Pathway Analysis and Selection

1. FDA路径分析与选择

Provide expert guidance on optimal FDA regulatory pathways ensuring efficient market access and regulatory compliance.
FDA Pathway Decision Framework:
FDA REGULATORY PATHWAY SELECTION
├── Device Classification Determination
│   ├── Predicate device identification
│   ├── Classification database research
│   ├── Classification panel consultation
│   └── De Novo pathway evaluation
├── Submission Pathway Selection
│   ├── 510(k) Clearance Assessment
│   │   ├── Traditional 510(k)
│   │   ├── Special 510(k)
│   │   └── Abbreviated 510(k)
│   ├── PMA (Premarket Approval) Evaluation
│   │   ├── Original PMA
│   │   ├── Panel-track supplement
│   │   └── Real-time supplement
│   └── De Novo Classification Request
│       ├── Novel device evaluation
│       ├── Risk classification
│       └── Special controls development
└── Pre-submission Strategy
    ├── Q-Sub meeting planning
    ├── FDA feedback integration
    ├── Submission timeline optimization
    └── Risk mitigation planning
提供最优FDA监管路径的专业指导，确保高效的市场准入与合规性。
FDA监管路径决策框架：
FDA REGULATORY PATHWAY SELECTION
├── Device Classification Determination
│   ├── Predicate device identification
│   ├── Classification database research
│   ├── Classification panel consultation
│   └── De Novo pathway evaluation
├── Submission Pathway Selection
│   ├── 510(k) Clearance Assessment
│   │   ├── Traditional 510(k)
│   │   ├── Special 510(k)
│   │   └── Abbreviated 510(k)
│   ├── PMA (Premarket Approval) Evaluation
│   │   ├── Original PMA
│   │   ├── Panel-track supplement
│   │   └── Real-time supplement
│   └── De Novo Classification Request
│       ├── Novel device evaluation
│       ├── Risk classification
│       └── Special controls development
└── Pre-submission Strategy
    ├── Q-Sub meeting planning
    ├── FDA feedback integration
    ├── Submission timeline optimization
    └── Risk mitigation planning

2. Quality System Regulation (QSR) 21 CFR 820 Compliance

2. 质量体系法规（QSR）21 CFR 820合规

Ensure comprehensive compliance with FDA Quality System Regulation throughout medical device lifecycle.
QSR Compliance Framework:
  1. Design Controls (21 CFR 820.30)
    • Design planning and procedures
    • Design input requirements and documentation
    • Design output specifications and verification
    • Design review, verification, and validation
    • Design transfer and change control
  2. Management Responsibility (21 CFR 820.20)
    • Quality policy establishment and communication
    • Organizational structure and responsibility
    • Management representative designation
    • Management review process implementation
  3. Document Controls (21 CFR 820.40)
    • Document approval and distribution procedures
    • Document change control processes
    • Document retention and access management
    • Obsolete document control
  4. Corrective and Preventive Actions (21 CFR 820.100)
    • CAPA System Implementation: Follow references/fda-capa-requirements.md
    • Investigation and root cause analysis procedures
    • Corrective action implementation and verification
    • Preventive action identification and implementation
确保医疗设备全生命周期内全面符合FDA质量体系法规要求。
QSR合规框架：
  1. 设计控制（21 CFR 820.30）
    • 设计规划与流程
    • 设计输入要求与文档记录
    • 设计输出规范与验证
    • 设计评审、验证与确认
    • 设计转移与变更控制
  2. 管理职责（21 CFR 820.20）
    • 质量方针的制定与传达
    • 组织结构与职责划分
    • 管理者代表任命
    • 管理评审流程实施
  3. 文档控制（21 CFR 820.40）
    • 文档审批与分发流程
    • 文档变更控制流程
    • 文档留存与访问管理
    • 失效文档管控
  4. 纠正与预防措施（21 CFR 820.100）
    • CAPA系统实施：参考references/fda-capa-requirements.md
    • 调查与根本原因分析流程
    • 纠正措施实施与验证
    • 预防措施识别与执行

3. FDA Submission Preparation and Management

3. FDA申报准备与管理

Lead comprehensive FDA submission preparation ensuring regulatory compliance and approval success.
510(k) Submission Process:
  1. Pre-submission Activities
    • Predicate device analysis and substantial equivalence strategy
    • Q-Sub meeting preparation and FDA consultation
    • Testing strategy development and validation
    • Decision Point: Determine submission readiness and pathway confirmation
  2. 510(k) Preparation
    • Device Description: Comprehensive device characterization
    • Indications for Use: Clinical indication and patient population
    • Substantial Equivalence Comparison: Predicate device analysis
    • Performance Testing: Bench testing, biocompatibility, software validation
    • Labeling: Instructions for use and contraindications
  3. FDA Review Management
    • FDA communication and additional information responses
    • Review timeline monitoring and management
    • FDA questions and clarification coordination
    • Clearance letter processing and market launch preparation
PMA Submission Process:
  1. Clinical Investigation Requirements
    • IDE (Investigational Device Exemption) strategy and submission
    • Clinical study protocol development and validation
    • Good Clinical Practice (GCP) compliance oversight
    • Clinical data analysis and statistical evaluation
  2. PMA Application Preparation
    • Manufacturing information and quality system documentation
    • Clinical and nonclinical safety and effectiveness data
    • Risk analysis and benefit-risk assessment
    • Labeling and post-market study commitments
主导全面的FDA申报准备工作，确保合规性与获批成功率。
510(k)申报流程：
  1. 预申报活动
    • predicate设备分析与实质等效性策略
    • Q-Sub会议准备与FDA咨询
    • 测试策略制定与验证
    • 决策点：确定申报就绪状态与路径确认
  2. 510(k)申报准备
    • 设备描述：全面的设备特征说明
    • 适用范围：临床适应症与患者人群
    • 实质等效性对比：predicate设备分析
    • 性能测试：台架测试、生物相容性、软件验证
    • 标签：使用说明与禁忌症
  3. FDA评审管理
    • FDA沟通与补充信息回复
    • 评审时间线监控与管理
    • FDA问题与澄清协调
    • clearance函处理与上市准备
PMA申报流程：
  1. 临床研究要求
    • IDE（研究性器械豁免）策略与申报
    • 临床研究方案制定与验证
    • 良好临床实践（GCP）合规监督
    • 临床数据分析与统计评估
  2. PMA申请准备
    • 制造信息与质量体系文档
    • 临床与非临床安全性及有效性数据
    • 风险分析与获益-风险评估
    • 标签与上市后研究承诺

4. HIPAA Compliance and Healthcare Data Protection

4. HIPAA合规与医疗数据保护

Ensure comprehensive HIPAA compliance for medical devices handling protected health information (PHI).
HIPAA Compliance Framework:
HIPAA COMPLIANCE REQUIREMENTS
├── Administrative Safeguards
│   ├── Security officer designation
│   ├── Workforce training and access management
│   ├── Information access management
│   └── Security awareness and training
├── Physical Safeguards
│   ├── Facility access controls
│   ├── Workstation use restrictions
│   ├── Device and media controls
│   └── Equipment disposal procedures
├── Technical Safeguards
│   ├── Access control systems
│   ├── Audit controls and monitoring
│   ├── Integrity controls
│   ├── Person or entity authentication
│   └── Transmission security
└── Business Associate Requirements
    ├── Business associate agreements
    ├── Subcontractor management
    ├── Breach notification procedures
    └── Risk assessment documentation
HIPAA Risk Assessment Process:
  1. PHI Data Flow Analysis
    • PHI collection, storage, and transmission mapping
    • Data access point identification and control
    • Third-party data sharing evaluation
    • Data retention and disposal procedures
  2. Technical Safeguard Implementation
    • For Connected Devices: Follow references/device-cybersecurity-guidance.md
    • For Software Systems: Follow references/software-hipaa-compliance.md
    • For Cloud Services: Follow references/cloud-hipaa-requirements.md
    • Encryption and access control verification
确保处理受保护健康信息（PHI）的医疗设备全面符合HIPAA要求。
HIPAA合规框架：
HIPAA COMPLIANCE REQUIREMENTS
├── Administrative Safeguards
│   ├── Security officer designation
│   ├── Workforce training and access management
│   ├── Information access management
│   └── Security awareness and training
├── Physical Safeguards
│   ├── Facility access controls
│   ├── Workstation use restrictions
│   ├── Device and media controls
│   └── Equipment disposal procedures
├── Technical Safeguards
│   ├── Access control systems
│   ├── Audit controls and monitoring
│   ├── Integrity controls
│   ├── Person or entity authentication
│   └── Transmission security
└── Business Associate Requirements
    ├── Business associate agreements
    ├── Subcontractor management
    ├── Breach notification procedures
    └── Risk assessment documentation
HIPAA风险评估流程：
  1. PHI数据流分析
    • PHI收集、存储与传输映射
    • 数据访问点识别与管控
    • 第三方数据共享评估
    • 数据留存与处置流程
  2. 技术保障措施实施
    • 针对联网设备：参考references/device-cybersecurity-guidance.md
    • 针对软件系统：参考references/software-hipaa-compliance.md
    • 针对云服务：参考references/cloud-hipaa-requirements.md
    • 加密与访问控制验证

Advanced FDA Regulatory Applications

高级FDA监管应用

Software as Medical Device (SaMD) Regulation

软件即医疗设备（SaMD）监管

Navigate complex FDA requirements for software-based medical devices ensuring compliance and efficient approval.
SaMD Regulatory Strategy:
  • Software Classification: SaMD risk categorization per FDA guidance
  • Software Documentation: Software lifecycle documentation per FDA requirements
  • Cybersecurity Requirements: FDA cybersecurity guidance implementation
  • Change Control: Software modification and FDA notification requirements
导航基于软件的医疗设备的复杂FDA要求，确保合规性与高效获批。
SaMD监管策略：
  • 软件分类：根据FDA指南进行SaMD风险分类
  • 软件文档：符合FDA要求的软件全生命周期文档
  • 网络安全要求：FDA网络安全指南实施
  • 变更控制：软件修改与FDA通知要求

Combination Product Regulation

组合产品监管

Manage FDA combination product requirements ensuring proper classification and regulatory pathway selection.
Combination Product Framework:
  • OPDP Assignment: Office of Product Development and Policy consultation
  • Lead Center Determination: CDER, CDRH, or CBER assignment
  • Intercenter Agreement: Cross-center coordination and communication
  • Combination Product Guidance: Product-specific regulatory guidance
管理FDA组合产品要求，确保正确分类与监管路径选择。
组合产品框架：
  • OPDP分配：产品开发与政策办公室咨询
  • 主导中心确定：CDER、CDRH或CBER分配
  • 跨中心协议：跨中心协调与沟通
  • 组合产品指南：产品特定监管指南

FDA Cybersecurity Compliance

FDA网络安全合规

Implement comprehensive cybersecurity measures meeting FDA requirements and guidance.
FDA Cybersecurity Requirements:
  1. Premarket Cybersecurity Requirements
    • Cybersecurity risk assessment and management
    • Software bill of materials (SBOM) documentation
    • Cybersecurity controls implementation and verification
    • Vulnerability disclosure and management procedures
  2. Post-market Cybersecurity Obligations
    • Cybersecurity monitoring and threat intelligence
    • Security update and patch management
    • Incident response and reporting procedures
    • Coordinated vulnerability disclosure programs
实施全面的网络安全措施，满足FDA要求与指南。
FDA网络安全要求：
  1. 上市前网络安全要求
    • 网络安全风险评估与管理
    • 软件物料清单（SBOM）文档
    • 网络安全控制措施实施与验证
    • 漏洞披露与管理流程
  2. 上市后网络安全义务
    • 网络安全监控与威胁情报
    • 安全更新与补丁管理
    • 事件响应与报告流程
    • 协调漏洞披露计划

FDA Inspection Readiness

FDA检查准备

FDA Inspection Preparation

FDA检查准备

Ensure comprehensive readiness for FDA inspections including QSR compliance verification and documentation review.
Inspection Readiness Protocol:
  • Quality System Assessment: QSR compliance verification and gap analysis
  • Documentation Review: Record completeness and regulatory compliance
  • Personnel Training: Inspection response and communication training
  • Mock Inspection: Internal inspection simulation and improvement
确保全面做好FDA检查准备，包括QSR合规验证与文档审核。
检查准备规程：
  • 质量体系评估：QSR合规验证与差距分析
  • 文档审核：记录完整性与合规性检查
  • 人员培训：检查响应与沟通培训
  • 模拟检查：内部检查模拟与改进

FDA Warning Letter Response

FDA警告函响应

Manage FDA warning letter responses ensuring comprehensive corrective action and regulatory compliance restoration.
Warning Letter Response Strategy:
  1. Root Cause Analysis: Systematic investigation and problem identification
  2. Corrective Action Plan: Comprehensive CAPA implementation
  3. FDA Communication: Professional response and timeline management
  4. Verification Activities: Effectiveness verification and compliance demonstration
管理FDA警告函回复，确保全面的纠正措施与合规性恢复。
警告函响应策略：
  1. 根本原因分析：系统性调查与问题识别
  2. 纠正措施计划：全面的CAPA实施
  3. FDA沟通：专业回复与时间线管理
  4. 验证活动：有效性验证与合规性证明

Regulatory Intelligence and Strategy

监管情报与战略

FDA Guidance Monitoring

FDA指南监控

Maintain current awareness of FDA guidance development and regulatory policy changes.
FDA Intelligence System:
  • Guidance Document Monitoring: New and revised guidance tracking
  • FDA Policy Changes: Regulatory policy evolution and impact assessment
  • Industry Communication: FDA workshops, conferences, and stakeholder meetings
  • Warning Letter Analysis: Industry trends and enforcement patterns
持续关注FDA指南制定与监管政策变化。
FDA情报系统：
  • 指南文档监控：新发布与修订指南跟踪
  • FDA政策变化：监管政策演变与影响评估
  • 行业沟通：FDA研讨会、会议与利益相关方会议
  • 警告函分析：行业趋势与执法模式

Market Access Strategy

市场准入战略

Develop comprehensive market access strategies optimizing FDA regulatory pathways and commercial objectives.
Market Access Planning:
  • Regulatory Strategy Development: Pathway optimization and risk mitigation
  • Competitive Intelligence: Regulatory landscape analysis and positioning
  • Timeline Optimization: Regulatory milestone planning and resource allocation
  • Commercial Integration: Regulatory strategy and business objective alignment
制定全面的市场准入战略，优化FDA监管路径与商业目标。
市场准入规划：
  • 监管战略制定：路径优化与风险缓解
  • 竞争情报：监管格局分析与定位
  • 时间线优化：监管里程碑规划与资源分配
  • 商业整合：监管战略与业务目标对齐

Resources

资源

scripts/

scripts/

  • fda-submission-tracker.py
    : FDA submission status monitoring and timeline management
  • qsr-compliance-checker.py
    : QSR compliance assessment and gap analysis tool
  • hipaa-risk-assessment.py
    : HIPAA compliance evaluation and documentation
  • fda-guidance-monitor.py
    : FDA guidance and policy change monitoring
  • fda-submission-tracker.py
    ：FDA申报状态监控与时间线管理
  • qsr-compliance-checker.py
    ：QSR合规评估与差距分析工具
  • hipaa-risk-assessment.py
    ：HIPAA合规评估与文档生成
  • fda-guidance-monitor.py
    ：FDA指南与政策变化监控

references/

references/

  • fda-submission-guide.md
    : Comprehensive FDA submission preparation framework
  • qsr-compliance-requirements.md
    : 21 CFR 820 compliance implementation guide
  • hipaa-compliance-framework.md
    : Complete HIPAA compliance requirements
  • device-cybersecurity-guidance.md
    : FDA cybersecurity requirements and implementation
  • fda-capa-requirements.md
    : FDA CAPA system requirements and best practices
  • fda-submission-guide.md
    ：全面的FDA申报准备框架
  • qsr-compliance-requirements.md
    ：21 CFR 820合规实施指南
  • hipaa-compliance-framework.md
    ：完整的HIPAA合规要求
  • device-cybersecurity-guidance.md
    ：FDA网络安全要求与实施
  • fda-capa-requirements.md
    ：FDA CAPA系统要求与最佳实践

assets/

assets/

  • fda-templates/
    : FDA submission templates, forms, and checklists
  • qsr-documentation/
    : QSR compliance documentation templates
  • hipaa-tools/
    : HIPAA compliance assessment and documentation tools
  • inspection-materials/
    : FDA inspection preparation and response materials
  • fda-templates/
    ：FDA申报模板、表单与检查清单
  • qsr-documentation/
    ：QSR合规文档模板
  • hipaa-tools/
    ：HIPAA合规评估与文档工具
  • inspection-materials/
    ：FDA检查准备与响应材料